Patents by Inventor Bandari Rajendra Prasad

Bandari Rajendra Prasad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8461150
    Abstract: The present invention relates to chalcone linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation there of. More particularly it relates to 7-Methoxy-8-{n[4-1-(2 or 4-substituted phenyl)-3-(4-hydroxy-3-methoxyphenyl)-2-propen-1-one]alkyl}-oxy}-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one and 7-Methoxy-8-{n-[-3-(4-hydroxy-3-methoxyphenyl)-1-(2,4-alkyl-3-quinolyl)-2-propen-1-one]alkyl}-oxy-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one with aliphatic chain length variations useful as anticancer (antitumor) agent. The general structural formula of these chalcone linked pyrrolo[2,1-c][1,4]benzodiazepines hybrids is given below. wherein R1=OH, methyl, ethyl or phenyl; R2=H, OH or F; R=H or methyl; x=c or N; n=1-4.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: June 11, 2013
    Assignee: Council of Scientific & Industrial Research
    Inventors: Ahmed Kamal, Bandari Rajendra Prasad, Adla Malla Reddy
  • Patent number: 8394954
    Abstract: Disclosed herein are benzophenone hybrids with potent anticancer activities and processes for creation of the same.
    Type: Grant
    Filed: March 26, 2008
    Date of Patent: March 12, 2013
    Assignee: Council of Scientific & Industrial Research
    Inventors: Ahmed Kamal, Bandari Rajendra Prasad
  • Patent number: 8309726
    Abstract: The present invention provides novel anthranilic acid derivative useful as potential anticancer agent. More particularly, the present invention relates novel anthranilic acid derivative of general formula (8), R?=alkyl-2-methoxyphenyl piperazine or benzyl; R=2-methoxyphenyl, piperazine, 2-pyridyl piperazine-1-yl, 2-pyrimidyl piperazine-1-yl, 4-quinazolinyl piperazine-1-yl, 9H-9-fluorenylamine, 4-{(2{amino-5-(methoxy)-4-[(phenylmethyl)oxy]phenyl}carbonyl)-hexahydro-1-pyrazinyl], and [(4[2-amino-4-(benzyloxy)-5-methoxybenzoyl]aminophenyl)-sulfonyl]-4-benzamine; X?H or pyrazine-2-carbonyl. The present invention also provides a process for the preparation of novel anthranilic acid derivative of general formula (8), which is useful as potential anticancer agent.
    Type: Grant
    Filed: March 13, 2008
    Date of Patent: November 13, 2012
    Assignee: Council of Scientific & Industrial Research
    Inventors: Ahmed Kamal, Bandari Rajendra Prasad
  • Patent number: 8153627
    Abstract: The present invention provides a compound of general formula 5, useful as potential antitumour agents against human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2,1-c][1,4]benzodiazepine hybrids of general formula (5): wherein n=3, 4, 5, 6, 8 and wherein R1 and R2 is selected from the group consisting of R1?H, R2?H or R1?CH3O, R2=CH3O or R1?CH3O and R2?C2H5O.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: April 10, 2012
    Assignee: Council of Scientific & Industrial Research
    Inventors: Ahmed Kamal, Bandari Rajendra Prasad, Adla Malla Reddy
  • Publication number: 20110201600
    Abstract: The present invention relates to chalcone linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation there of. More particularly it relates to 7-Methoxy-8-{n[4-1-(2 or 4-substituted phenyl)-3-(4-hydroxy-3-methoxyphenyl)-2-propen-1-one]alkyl}-oxy}-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one and 7-Methoxy-8-{n[-3-(4-hydroxy-3-methoxyphenyl)-1-(2,4-alkyl-3-quinolyl)-2-propen-1-one]alkyl}-oxy-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one with aliphatic chain length variations useful as anticancer (antitumour) agent. The general structural formula of these chalcone linked pyrrolo[2,1-c][1,4]benzodiazepines hybrids is given below.
    Type: Application
    Filed: October 31, 2008
    Publication date: August 18, 2011
    Inventors: Ahmed Kamal, Bandari Rajendra Prasad, Adla Malla Reddy
  • Publication number: 20110046111
    Abstract: The present invention provides a compound of general formula 5, useful as potential antitumour agents against human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2,1-c][1,4]benzodiazepine hybrids of general formula (5): wherein n=3, 4, 5, 6, 8 and wherein R1 and R2 is selected from the group consisting of R1?H, R2?H or R1?CH3O, R2=CH3O or R1?CH3O and R2?C2H5O.
    Type: Application
    Filed: October 31, 2008
    Publication date: February 24, 2011
    Inventors: Ahmed Kamal, Bandari Rajendra Prasad, Adla Malla Reddy
  • Publication number: 20100174074
    Abstract: Disclosed herein are benzophenone hybrids with potent anticancer activities and processes for creation of the same.
    Type: Application
    Filed: March 26, 2008
    Publication date: July 8, 2010
    Inventors: Ahmed Kamal, Bandari Rajendra Prasad
  • Publication number: 20100016589
    Abstract: The present invention provides novel anthranilic acid derivative useful as potential anticancer agent. More particularly, the present invention relates novel anthranilic acid derivative of general formula (8), R?=alkyl-2-methoxyphenyl piperazine (or) benzyl, R=2 methoxy phenyl, piperazine, 2-pyridyl piperazine, 2-pyrimidyl piperazine, 4-quinazolinyl piperazine, 9H-9-fluorenylamine, 4-{(2{amino-5-(methoxy)-4-[(phenylmethyl)oxy]phenyl}carbonyl)hexahydro-1-pyrazinyl], and [(4[2 amino-4-(benzyloxy)-5-methoxybenzoyl]aminophenyl)sulfonyl]-4-benzamine; X?H (or) pyrazine-2-carbonyl. The present invention also provides a process for the preparation of novel anthranilic acid derivative of general formula (8), which is useful as potential anticancer agent.
    Type: Application
    Filed: March 13, 2008
    Publication date: January 21, 2010
    Inventors: Ahmed Kamal, Bandari Rajendra Prasad